|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Loan receivable held at carrying value, net | ||||||||||
| Loans held for investment at carrying value, net | ||||||||||
| Current expected credit loss reserve | ||||||||||
| Loans held for investment at carrying value, net of current expected credit loss reserve | ||||||||||
| Cash and cash equivalents | ||||||||||
| Interest receivable | ||||||||||
| Investment in unconsolidated real estate joint venture | ||||||||||
| Prepaid expenses and other assets | ||||||||||
| Total assets | ||||||||||
| Liabilities | ||||||||||
| Due to affiliate | ||||||||||
| Accrued interest | ||||||||||
| Dividends payable | ||||||||||
| Current expected credit loss reserve | ||||||||||
| Accrued management and incentive fees | ||||||||||
| Accrued direct administrative expenses | ||||||||||
| Accounts payable and other liabilities | ||||||||||
| Line of credit payable | ||||||||||
| Nonrelated Party | ||||||||||
| Related Party | ||||||||||
| Total line of credit payable | ||||||||||
| Total liabilities | ||||||||||
| Shareholders' equity | ||||||||||
| Preferred stock, par value $0.01 per share, 10,000 shares authorized at September 30, 2026 and December 31, 2025 and 0 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively | ||||||||||
| Common stock, par value $0.01 per share, 50,000,000 shares authorized at September 30, 2026 and December 31, 2025 and 13,515,851 and 13,420,986 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively | ||||||||||
| Additional paid-in capital | ||||||||||
| Accumulated (deficit) earnings | ||||||||||
| Total shareholders' equity | ||||||||||
| Total liabilities and shareholders' equity | ||||||||||
| Preferred stock, authorized (in shares) |
Loading...